Skip to main content

Articles

Page 1 of 55

  1. Circulating MicroRNAs (miRNAs) carried by microvesicles (MVs) have various physiological and pathological functions by post-transcriptional regulation of gene expression being considered markers for many disea...

    Authors: Miruna Nemecz, Diana Simona Stefan, Ioana Karla Comarița, Alina Constantin, Gabriela Tanko, Cristian Guja and Adriana Georgescu
    Citation: Cardiovascular Diabetology 2023 22:260
    Content type: Research Published on:

  3. The relationship of cumulative remnant-cholesterol (Cum-RC) concentration with the risk of cardiovascular disease (CVD) in patients with hypertension remains unclear.

    Authors: Weiqiang Wu, Guanzhi Chen, Kuangyi Wu, Huancong Zheng, Yanjuan Chen, Xianxuan Wang, Zegui Huang, Zefeng Cai, Zhiwei Cai, Zhichao Chen, Yulong Lan, Shuohua Chen, Shouling Wu and Youren Chen
    Citation: Cardiovascular Diabetology 2023 22:258
    Content type: Research Published on:

  5. Diabetic peripheral neuropathy (DPN) has been shown to be independently associated with cardiovascular events and mortality. This study aimed to evaluate changes in left ventricular (LV) microvascular perfusio...

    Authors: Xue-Ming Li, Rui Shi, Meng-Ting Shen, Wei-Feng Yan, Li Jiang, Chen-Yan Min, Xiao-Jing Liu, Ying-Kun Guo and Zhi-Gang Yang
    Citation: Cardiovascular Diabetology 2023 22:256
    Content type: Research Published on:

  6. The Atherogenic Index of Plasma (AIP) is a newly identified biomarker associated with lipid metabolism, demonstrating significant prognostic capabilities in individuals diagnosed with cardiovascular disease. H...

    Authors: Jiasuer Alifu, Lanqing Xiang, Wen Zhang, Penglong Qi, Huiying Chen, Lu Liu, Guoqing Yin, Abdul-Quddus Mohammed, Xian Lv, Tingting Shi, Fuad A. Abdu and Wenliang Che
    Citation: Cardiovascular Diabetology 2023 22:255
    Content type: Research Published on:

  7. Stroke was reported to be highly correlated with the triglyceride glucose-body mass index (TyG-BMI). Nevertheless, literature exploring the association between changes in the TyG-BMI and stroke incidence is sc...

    Authors: Rong-Rui Huo, Lu Zhai, Qian Liao and Xue-Mei You
    Citation: Cardiovascular Diabetology 2023 22:254
    Content type: Research Published on:

  8. Whether recent reductions in cardiovascular disease (CVD) events and mortality in type 2 diabetes apply equally to both sexes is largely unknown. The aim of this study was to characterize temporal changes in C...

    Authors: Wendy A. Davis and Timothy M. E. Davis
    Citation: Cardiovascular Diabetology 2023 22:253
    Content type: Research Published on:

  9. A healthy lifestyle (HL) has been inversely related to type 2 diabetes (T2D) and cardiovascular disease (CVD). However, few studies have identified a metabolite profile associated with HL. The present study ai...

    Authors: Santiago Rios, Jesús F. García-Gavilán, Nancy Babio, Indira Paz-Graniel, Miguel Ruiz-Canela, Liming Liang, Clary B Clish, Estefania Toledo, Dolores Corella, Ramón Estruch, Emilio Ros, Montserrat Fitó, Fernando Arós, Miquel Fiol, Marta Guasch-Ferré, José M Santos-Lozano…
    Citation: Cardiovascular Diabetology 2023 22:252
    Content type: Research Published on:

  10. Insulin resistance (IR) is a pathophysiologic hallmark of type 2 diabetes and associated with the presence of chronic kidney disease (CKD). Experimental studies suggest that endothelin-1 increases IR. We asses...

    Authors: J. David Smeijer, Donald E. Kohan, Peter Rossing, Ricardo Correa-Rotter, Adrian Liew, Sydney C.W. Tang, Dick de Zeeuw, Ron T. Gansevoort, Wenjun Ju and Hiddo J. Lambers Heerspink
    Citation: Cardiovascular Diabetology 2023 22:251
    Content type: Research Published on:

  11. Authors: You Zhou, Chi Wang, Hebin Che, Liting Cheng, Di Zhu, Chongyou Rao, Qin Zhong, Zongren Li, Xiao Wang, Zisheng Wu and Kunlun He
    Citation: Cardiovascular Diabetology 2023 22:250
    Content type: Correction Published on:

    The original article was published in Cardiovascular Diabetology 2023 22:171

  12. Circulating biomarkers of metabolic and cardiovascular diseases can help in the early detection and prevention of those diseases. Using proton nuclear magnetic resonance (1H-NMR), we aimed to study the plasma ...

    Authors: Juan Moreno-Vedia, Dídac Llop, Ricardo Rodríguez-Calvo, Núria Plana, Núria Amigó, Roser Rosales, Yaiza Esteban, Josefa Girona, Lluís Masana and Daiana Ibarretxe
    Citation: Cardiovascular Diabetology 2023 22:249
    Content type: Research Published on:

  13. Type 2 diabetes mellitus (T2DM) is a major global health issue and a significant risk factor for atherosclerosis. Atherosclerosis in T2DM patients has been associated with inflammation, insulin resistance, hyp...

    Authors: Louise Ménégaut, Aline Laubriet, Valentin Crespy, Damien Leleu, Thomas Pilot, Kevin Van Dongen, Jean-Paul Pais de Barros, Thomas Gautier, Jean-Michel Petit, Charles Thomas, Maxime Nguyen, Eric Steinmetz and David Masson
    Citation: Cardiovascular Diabetology 2023 22:248
    Content type: Research Published on:

  14. MicroRNAs (miRNAs) play a crucial role in regulating adaptive and maladaptive responses in cardiovascular diseases, making them attractive targets for potential biomarkers. However, their potential as novel bi...

    Authors: Mehrdad Samadishadlou, Reza Rahbarghazi, Zeynab Piryaei, Mahdad Esmaeili, Çığır Biray Avcı, Farhad Bani and Kaveh Kavousi
    Citation: Cardiovascular Diabetology 2023 22:247
    Content type: Research Published on:

  16. Diabetes mellitus (DM) is associated with thrombogenicity, clinically manifested with atherothrombotic events after percutaneous cutaneous intervention (PCI). This study aimed to investigate association betwee...

    Authors: Ki-Hyun Jeon, Young-Hoon Jeong, In-Ho Chae, Byeong-Keuk Kim, Hyung Joon Joo, Kiyuk Chang, Yongwhi Park, Young Bin Song, Sung Gyun Ahn, Sang Yeub Lee, Jung Rae Cho, Ae-Young Her, Hyo-Soo Kim, Moo Hyun Kim, Do-Sun Lim, Eun-Seok Shin…
    Citation: Cardiovascular Diabetology 2023 22:245
    Content type: Research Published on:

  17. Insulin resistance (IR) is a major metabolic disorder observed in heart failure (HF) and is tightly associated with patients’ poor prognosis. The triglyceride-glucose index (TyG) has been proposed as a surroga...

    Authors: Amirmohammad Khalaji, Amir Hossein Behnoush, Shaghayegh Khanmohammadi, Kimiya Ghanbari Mardasi, Sourena Sharifkashani, Amirhossein Sahebkar, Caterina Vinciguerra and Alessandro Cannavo
    Citation: Cardiovascular Diabetology 2023 22:244
    Content type: Research Published on:

  18. Endogenous estrogen is cardio-protective in healthy premenopausal women. Despite this favorable action of estrogen, animal models depict a detrimental effect of estradiol on vascular function in the presence o...

    Authors: Abigayle B. Simon, Cassandra C. Derella, Marsha Blackburn, Jeffrey Thomas, Lawrence C. Layman, Matthew S. Nicholson, Jennifer Waller, Ahmed Elmarakby, Karim M. Saad and Ryan A. Harris
    Citation: Cardiovascular Diabetology 2023 22:243
    Content type: Research Published on:

  21. To assess how inaccurately the body mass index (BMI) is used to diagnose obesity compared to body fat percentage (BF%) measurement and to compare the cardiometabolic risk in children and adolescents with or wi...

    Authors: J. Karina Zapata, M. Cristina Azcona-Sanjulian, Victoria Catalán, Beatriz Ramírez, Camilo Silva, Amaia Rodríguez, Javier Escalada, Gema Frühbeck and Javier Gómez-Ambrosi
    Citation: Cardiovascular Diabetology 2023 22:240
    Content type: Research Published on:

  22. High triglyceride-glucose index (TyG) is a major risk factor for heart failure, but the long-term effect of high TyG index on the risk of developing heart failure remains unclear. Therefore, we aimed to determ...

    Authors: Huancong Zheng, Guanzhi Chen, Kuangyi Wu, Weiqiang Wu, Zegui Huang, Xianxuan Wang, Zekai Chen, Zefeng Cai, Zhiwei Cai, Yulong Lan, Shouling Wu and Youren Chen
    Citation: Cardiovascular Diabetology 2023 22:239
    Content type: Research Published on:

  23. The triglyceride-glucose (TyG) index is a reliable surrogate marker of insulin resistance (IR). However, whether the TyG index has prognostic value in patients with moderate to severe aortic stenosis (AS) rema...

    Authors: Rihua Huang, Xinghao Xu, Chaoguang Xu, Shaozhao Zhang, Zhenyu Xiong, Menghui Liu, Yiquan Huang, Han Wen, Yue Guo, Xinxue Liao and Xiaodong Zhuang
    Citation: Cardiovascular Diabetology 2023 22:238
    Content type: Research Published on:

  24. Diabetes mellitus is a metabolic disease characterized by long-term hyperglycaemia, which leads to microangiopathy and macroangiopathy and ultimately increases the mortality of diabetic patients. Endothelial d...

    Authors: Ying An, Bu-tuo Xu, Sheng-rong Wan, Xiu-mei Ma, Yang Long, Yong Xu and Zong-zhe Jiang
    Citation: Cardiovascular Diabetology 2023 22:237
    Content type: Review Published on:

  25. The presence of type 1 diabetes mellitus (T1DM) has been demonstrated to pose an increased risk for developing cardiovascular diseases (CVDs). However, the causal relationships between T1DM and CVDs remain unc...

    Authors: Zirui Liu, Haocheng Wang, Zhengkai Yang, Yu Lu and Cao Zou
    Citation: Cardiovascular Diabetology 2023 22:236
    Content type: Research Published on:

  26. Randomized controlled trials (RCTs) reported contrasting results about reverse left ventricular remodeling (LVR) after sodium-glucose co-transporter-2 inhibitors (SGLT2i) therapy in patients with heart failure...

    Authors: Erberto Carluccio, Paolo Biagioli, Gianpaolo Reboldi, Anna Mengoni, Rosanna Lauciello, Cinzia Zuchi, Sandra D’Addario, Giuliana Bardelli and Giuseppe Ambrosio
    Citation: Cardiovascular Diabetology 2023 22:235
    Content type: Research Published on:

  27. Microvascular dysfunction plays a crucial role in complications of type 2 diabetes and might contribute to heart failure with preserved ejection fraction (HFpEF), a disease that disproportionally affects women...

    Authors: Elisa Dal Canto, L. van Deursen, A. G. Hoek, P. J. M. Elders, H. M. den Ruijter, J. van der Velden, V. van Empel, E. H. Serné, E. C. Eringa and J. W.J. Beulens
    Citation: Cardiovascular Diabetology 2023 22:234
    Content type: Research Published on:

  28. Studies that have reported lower risk for cardiovascular outcomes in users of Sodium–Glucose Cotransporter-2 Inhibitors (SGLT-2i) are limited by residual cofounding and lack of information on prior cardiovascu...

    Authors: Dorte Vistisen, Bendix Carstensen, Patorno Elisabetta, Stefanie Lanzinger, Elise Chia-Hui Tan, Daisuke Yabe, Dae Jung Kim, Wayne H.-H. Sheu, Cheli Melzer-Cohen, Reinhard W. Holl, Júlio Núñez, Kyoung Hwa Ha, Sigrun Halvorsen, Gisle Langslet, Avraham Karasik, Thomas Nyström…
    Citation: Cardiovascular Diabetology 2023 22:233
    Content type: Research Published on:

  29. Insulin resistance (IR) can be effectively assessed using the dependable surrogate biomarker triglyceride-glucose (TyG) index. In various critical care contexts, like contrast-induced acute kidney injury (AKI)...

    Authors: Zewen Yang, Hongxia Gong, Fuqiang Kan and Ningning Ji
    Citation: Cardiovascular Diabetology 2023 22:232
    Content type: Research Published on:

  30. Adipokines are hormones secreted from adipose tissue and are associated with cardiometabolic diseases (CMD). Functional differences between adipokines (leptin, adiponectin, and resistin) are known, but inconsi...

    Authors: Daeeun Kim, Aylin Memili, Hung-Hsin Chen, Heather M. Highland, Hannah G. Polikowsky, Mohammad Yaser Anwar, Susan T. Laing, Miryoung Lee, Joseph B. McCormick, Susan P. Fisher-Hoch, Jennifer E. Below, Kari E. North and Absalon D. Gutierrez
    Citation: Cardiovascular Diabetology 2023 22:231
    Content type: Research Published on:

  31. The triglyceride-glucose (TyG) index has been evaluated as a reliable surrogate for insulin resistance (IR) and has been proven to be a predictor of poor outcomes in patients with cardiovascular diseases. Howe...

    Authors: Zhenguo Wu, Lin Xie, Dachuan Guo, Sha Chen, Xiaoyu Liu, Xiangfei Sun, Juan Wang, Yerui Zhang, Li Liu, Huiliang Cui, Dejin Zang and Jianmin Yang
    Citation: Cardiovascular Diabetology 2023 22:230
    Content type: Research Published on:

  33. Today, diabetes mellitus (DM) has become a worldwide concern. DM is a major risk factor for the development of cardiovascular diseases (CVD). Eligible patients with CVD are treated invasively by percutaneous c...

    Authors: Hong Wang, Quannan Zu, Hairong Tang, Ming Lu, Rongfa Chen and Zhiren Yang
    Citation: Cardiovascular Diabetology 2023 22:228
    Content type: Review Published on:

  34. Outcomes of diabetes screening in contemporary, multi-ethnic populations are unknown. We examined the association of prior outpatient diabetes screening with the risks of cardiovascular events and mortality in...

    Authors: Calvin Ke, Anna Chu, Baiju R. Shah, Sheldon Tobe, Karen Tu, Jiming Fang, Haris Vaid, Peter Liu, Aishah Cader and Douglas S. Lee
    Citation: Cardiovascular Diabetology 2023 22:227
    Content type: Research Published on:

  35. The global prevalence of metabolic syndrome and its association with increased morbidity and mortality has been rigorously studied. However, the true prevalence of “metabolic health”, i.e. individuals without ...

    Authors: Hadas Ben-Assayag, Rafael Y. Brzezinski, Shlomo Berliner, David Zeltser, Itzhak Shapira, Ori Rogowski, Sharon Toker, Roy Eldor and Shani Shenhar-Tsarfaty
    Citation: Cardiovascular Diabetology 2023 22:226
    Content type: Research Published on:

  36. Estimated glucose disposal rate (eGDR), a simple and noninvasive measure of insulin resistance, has been proven to be an independent risk factor for first-time stroke and all-cause mortality. In this study, we...

    Authors: Zhengzhao Lu, Yunyun Xiong, Xueyan Feng, Kaixuan Yang, Hongqiu Gu, Xingquan Zhao, Xia Meng and Yongjun Wang
    Citation: Cardiovascular Diabetology 2023 22:225
    Content type: Research Published on:

  37. Diabetes and hyperlipidaemia are both risk factors for coronary artery disease, and both are associated with a high triglyceride-glucose index (TyG index). The TyG index has been presented as a marker of insul...

    Authors: Jiao Li, Zixian Dong, Hao Wu, Yue Liu, Yafang Chen, Si Li, Yufan Zhang, Xin Qi and Liping Wei
    Citation: Cardiovascular Diabetology 2023 22:224
    Content type: Research Published on:

  38. High-sensitivity C-reaction protein (hsCRP), a biomarker of residual inflammatory risk, has been demonstrated with poor cardiovascular outcomes. We aimed to investigate the prognostic value of hsCRP in patient...

    Authors: Le Li, Shangyu Liu, Zhuxin Zhang, Likun Zhou, Zhenhao Zhang, Yulong Xiong, Zhao Hu and Yan Yao
    Citation: Cardiovascular Diabetology 2023 22:223
    Content type: Research Published on:

  39. Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of morbidity and mortality, being twofold to fourfold more common in patients with type 2 diabetes mellitus (T2DM) than in individuals withou...

    Authors: Massimiliano Ruscica, Chiara Macchi, Angelica Giuliani, Alessandra Stefania Rizzuto, Deborah Ramini, Matilde Sbriscia, Stefano Carugo, Anna Rita Bonfigli, Alberto Corsini, Fabiola Olivieri and Jacopo Sabbatinelli
    Citation: Cardiovascular Diabetology 2023 22:222
    Content type: Research Published on:

  40. Early postoperative glycemic variability is associated with worse outcome after cardiac surgery, but the underlying mechanisms remain unknown. This study aimed to describe the relationship between postoperativ...

    Authors: Etienne Chazal, Lucas Morin, Sidney Chocron, Philippe Lassalle, Sebastien Pili-Floury, Lucie Salomon du Mont, David Ferreira, Emmanuel Samain, Andrea Perrotti and Guillaume Besch
    Citation: Cardiovascular Diabetology 2023 22:221
    Content type: Research Published on:

  41. Semaglutide is a glucose-lowering treatment for type 2 diabetes (T2D) with demonstrated cardiovascular benefits; semaglutide may also have kidney-protective effects. This post hoc analysis investigated the associ...

    Authors: Peter Rossing, Stephen C. Bain, Heidrun Bosch-Traberg, Ekaterina Sokareva, Hiddo J. L. Heerspink, Søren Rasmussen and Linda G. Mellbin
    Citation: Cardiovascular Diabetology 2023 22:220
    Content type: Research Published on:

  42. Clinical observations suggest a complex relationship between obesity and coronary artery disease (CAD). This study aimed to characterize the intermediate metabolism phenotypes among obese patients with CAD and...

    Authors: Chong-Yu Zhang, Ru-Qin Xu, Xiao-Qiao Wang, Lin-Feng Sun, Pei Mo, Ren-Jie Cai, Xiao-Zhen Lin, Cheng-Feng Luo, Wen-Chao Ou, Lie-Jing Lu, Yun Zhong and Jia-Yuan Chen
    Citation: Cardiovascular Diabetology 2023 22:219
    Content type: Research Published on:

  43. As cardiovascular disease (CVD) is a leading cause of death for patients with diabetes mellitus (DM), we aimed to find important factors that predict cardiovascular (CV) risk using a machine learning (ML) appr...

    Authors: Hanna Kwiendacz, Agata M. Wijata, Jakub Nalepa, Julia Piaśnik, Justyna Kulpa, Mikołaj Herba, Sylwia Boczek, Kamil Kegler, Mirela Hendel, Krzysztof Irlik, Janusz Gumprecht, Gregory Y. H. Lip and Katarzyna Nabrdalik
    Citation: Cardiovascular Diabetology 2023 22:218
    Content type: Research Published on:

  44. Agonism at the receptor for the glucose-dependent insulinotropic polypeptide (GIPR) is a key component of the novel unimolecular GIPR:GLP-1R co-agonists, which are among the most promising drugs in clinical de...

    Authors: Stephan Sachs, Anna Götz, Brian Finan, Annette Feuchtinger, Richard D. DiMarchi, Yvonne Döring, Christian Weber, Matthias H. Tschöp, Timo D. Müller and Susanna M. Hofmann
    Citation: Cardiovascular Diabetology 2023 22:217
    Content type: Research Published on:

  45. Myocardial microvascular injury is the key event in early diabetic heart disease. The injury of myocardial microvascular endothelial cells (CMECs) is the main cause and trigger of myocardial microvascular dise...

    Authors: Xide Shi, Chao Liu, Jiangwei Chen, Shiqiang Zhou, Yajuan Li, Xingcheng Zhao, Jinliang Xing, Junhui Xue, Fengzhou Liu and Fei Li
    Citation: Cardiovascular Diabetology 2023 22:216
    Content type: Research Published on:

  46. In AFFIRM-AHF, treatment of iron deficiency with intravenous ferric carboxymaltose (FCM) reduced the risk of heart failure (HF) hospitalization and improved quality of life (QoL) vs placebo in patients stabili...

    Authors: Giuseppe Rosano, Piotr Ponikowski, Cristiana Vitale, Stefan D. Anker, Javed Butler, Vincent Fabien, Gerasimos Filippatos, Bridget-Anne Kirwan, Iain C. Macdougall, Marco Metra, Frank Ruschitzka, Vasuki Kumpeson, Udo-Michael Goehring, Peter van der Meer and Ewa A. Jankowska
    Citation: Cardiovascular Diabetology 2023 22:215
    Content type: Research Published on:

  47. While a low-carbohydrate diet (LCD) reduces HbA1c in patients with type 2 diabetes (T2D), the associated high intake of fat may adversely affect cardiovascular risk factors. To address this, we examined the ef...

    Authors: Eva M. Gram-Kampmann, Thomas B. Olesen, Camilla D. Hansen, Mie B. Hugger, Jane M. Jensen, Aase Handberg, Henning Beck-Nielsen, Aleksander Krag, Michael H. Olsen and Kurt Højlund
    Citation: Cardiovascular Diabetology 2023 22:212
    Content type: Research Published on:

  48. Heterogeneous metabolic clusters have been identified in diabetic and prediabetic states. It is not known whether such pathophysiologic clusters impact survival in at-risk persons being evaluated for coronary ...

    Authors: Katsiaryna Prystupa, Graciela E. Delgado, Angela P. Moissl, Marcus E. Kleber, Andreas L. Birkenfeld, Martin Heni, Andreas Fritsche, Winfried März and Robert Wagner
    Citation: Cardiovascular Diabetology 2023 22:211
    Content type: Research Published on:

  49. Atherogenic index of plasma (AIP) has been confirmed as a novel marker for myocardial infarction (MI), but few evidence on the long-term AIP and MI risk in general populations. We thus aimed to evaluate the re...

    Authors: Yijun Zhang, Shuohua Chen, Xue Tian, Penglian Wang, Qin Xu, Xue Xia, Xiaoli Zhang, Jing Li, Fen Liu, Shouling Wu and Anxin Wang
    Citation: Cardiovascular Diabetology 2023 22:210
    Content type: Research Published on:

  50. The concept of early vascular aging (EVA) represents a potentially beneficial model for future research into the pathophysiological mechanisms underlying the early manifestations of cardiovascular disease. For...

    Authors: Alicia Saz-Lara, Iván Cavero-Redondo, Carlos Pascual-Morena, Irene Martínez-García, Eva Rodríguez-Gutiérrez, Maribel Lucerón-Lucas-Torres, Bruno Bizzozero-Peroni, Nerea Moreno-Herráiz and Arturo Martínez-Rodrigo
    Citation: Cardiovascular Diabetology 2023 22:209
    Content type: Research Published on:
journal logo

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Submit manuscript

Annual Journal Metrics

  • 2022 Citation Impact
    9.3 - 2-year Impact Factor
    9.6 - 5-year Impact Factor
    2.054 - SNIP (Source Normalized Impact per Paper)
    2.361 - SJR (SCImago Journal Rank)

    2022 Speed
    2 days submission to first editorial decision for all manuscripts (Median)
    55 days submission to accept (Median)

    2022 Usage 
    2,116,496 downloads
    14,109 Altmetric mentions 

Cardiovascular Diabetology

ISSN: 1475-2840